# Enhancing sleep slow waves with auditory stimulation in people with Parkinson's disease: a randomized proof-of-concept trial.

- **DOI:** [10.1038/s41598-026-53443-1](https://doi.org/10.1038/s41598-026-53443-1)
- **Rating:** Sound (3.6 out of 5)
- **Verdict:** At-home PTAS credibly enhances stimulated-window slow-wave activity in selected Parkinson’s patients, but the small responder-enriched sample limits clinical inference.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1038%2Fs41598-026-53443-1

## Key claims

1. PTAS increased low-frequency SWA by almost 30% during ON windows, with corresponding increases in slow-wave amplitudes, in 21 analyzed participants.
   - Support: Tentative
   - Type: Primary finding
   - Basis: peak-bin ON-window estimate with uncorrected frequency testing and offsetting decreases during OFF windows
   - Location: Abstract; Results, Slow-Wave Activity; Fig. 3a–b; Table 2
2. Our main finding is that PTAS increases slow-wave activity (SWA) in PD patients, in a dose-dependent manner.
   - Support: Tentative
   - Type: Secondary
   - Basis: stimulus count also rises when endogenous SWA is intrinsically higher, limiting identification of dose dependence
   - Location: Discussion, opening paragraph; Results, Fig. 3c
3. Whole-night PTAS — but not part-night PTAS — showed a trend toward longer wake after sleep onset and lower sleep efficiency.
   - Support: Tentative
   - Type: Secondary
   - Basis: carefully hedged trend from small, unmatched protocol-duration subgroups not randomized against each other
   - Location: Abstract; Results, Sleep Macrostructure; Table S3
4. Participants receiving part-night PTAS reported improved subjective daytime sleepiness after the third night.
   - Support: Tentative
   - Type: Secondary
   - Basis: one positive outcome in an n=8 post hoc subgroup amid multiple uncorrected subjective tests
   - Location: Abstract; Results, Subjective Outcomes; Fig. 4
5. No relevant adverse events occurred.
   - Support: Tentative
   - Type: Secondary
   - Basis: three-night exposure in 21 participants with no detailed systematic adverse-event collection procedure
   - Location: Abstract; Results, Subjective Outcomes

## Strengths

- **Randomized within-person sham comparison** The counterbalanced crossover design compares three PTAS nights with three sham nights within participants, with participant and outcome-assessor blinding and a four-night washout.
  - Dimension: methodological rigour
  - Location: Methods, Study Design and Intervention; Fig. 1
- **Home-based physiological target engagement** PTAS increased low-frequency SWA during ON windows and increased slow-wave peak-to-peak amplitude, showing that the wearable intervention can engage its intended EEG target at home.
  - Dimension: contribution
  - Location: Results, Slow-Wave Activity; Fig. 3b; Table 2
- **Limitations shape the interpretation** The paper explicitly states that protocol-duration groups were unmatched, part-night findings are anecdotal, and exclusion of non-engagers prevents judging efficacy across Parkinson’s disease broadly.
  - Dimension: positioning
  - Location: Discussion, Limitations and Further Implications

## Limitations

- **Protocol change creates weak subgroups** The switch from whole-night to part-night stimulation occurred after 14 participants, leaving non-randomized groups of 13 and 8 analyzed participants with demographic and clinical differences. Sleep-continuity and sleepiness comparisons are therefore hypothesis-generating.
  - Dimension: methodological rigour
  - Location: Methods, Phase-Targeted Auditory Stimulation; Discussion, Effects of PTAS on Sleep in PD
- **Multiplicity inflates exploratory findings** Frequency bins and numerous subjective outcomes were tested at p<0.05 without a reported multiplicity strategy. The abstract highlights the maximum ON-window increase and one positive subjective result.
  - Dimension: methodological rigour
  - Location: Methods, Statistical Analysis; Results, Figs. 3–4
- **Selected sample narrows generalization** Five home-screened participants were excluded for absent neurophysiological engagement, enriching the analyzed sample for likely responders. The findings therefore do not estimate PTAS efficacy across the broader Parkinson’s population.
  - Dimension: application pathway
  - Location: Methods, Participants and Phase-Targeted Auditory Stimulation; Discussion, Limitations

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Clean. The reported numbers and statistics are consistent with the stated results.
- **Reporting and transparency:** Noted. The Results paragraph leaves the population for the daytime-sleepiness interaction unspecified, whereas Figure 4 explicitly assigns it to the part-night subgroup; this is an attribution ambiguity, not evidence of an incorrect statistic.
  - Conflict of interest: not stated · Ethics approval: declared · Preregistration: declared · Data availability: not stated · Code availability: not stated
- **Reference integrity:** Clean
  - 83 references in manuscript
  - 81 of 81 checkable references found in an index
  - 2 are books, websites or datasets — counted, but not index-checkable
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
